Role of immunosuppressive treatments based on mycophenolate mofetil in posttransplantation renal surgical complications.
Herrero
J C
JC
Nephrology and Urology Department, Hospital 12 de Octubre, Madrid, Spain.
Andrés
A
A
Leiva
O
O
Diaz
R
R
Polo
G
G
Aguirre
F
F
Villacampa
F
F
Rodicio
J L
JL
Gonzalez
E
E
Morales
J M
JM
Praga
M
M
D016572:Cyclosporine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology*; D008214:Lymphocytes / Q000187:drug effects / Q000276:immunology; D008875:Middle Aged; D009173:Mycophenolic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D011183:Postoperative Complications / Q000276:immunology*; D012189:Retrospective Studies; D016559:Tacrolimus / Q000627:therapeutic use; D014019:Tissue Donors / Q000706:statistics & numerical data
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D009173:Mycophenolic Acid; D016559:Tacrolimus